Abstract：
Upadacitinib, a selective JAK-1 inhibitor, was used as rescue therapy for ulcerative colitis in the setting of pregnancy following use of mesalamine, vedolizumab, infliximab, and corticosteroids. This resulted in an uncomplicated live full birth without need for surgical intervention.
摘要：
Upadacitinib,一种选择性JAK-1抑制剂,在使用美沙拉嗪后的妊娠中用作溃疡性结肠炎的抢救疗法，维多珠单抗,英夫利昔单抗,和皮质类固醇。这导致了一个简单的活产，无需手术干预。
